New Key Statistics Module, Z-Score and F-Score
DHA:ACMELAB Key Ratios
Market Cap BDT M | 18,049.63 |
Enterprise Value BDT M | 39,432.68 |
P/E(ttm) | 9.74 |
PE Ratio without NRI | 9.74 |
Forward PE Ratio | -- |
Price/Book | 0.74 |
Price/Sales | 0.78 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | 4.02 |
Payout Ratio % | -- |
Revenue (TTM) BDT M | 23,195.00 |
EPS (TTM) BDT | 8.77 |
Beneish M-Score | -2.51 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 7.00 |
y-y EBITDA Growth Rate % | 15.10 |
EV-to-EBIT | 10.28 |
EV-to-EBITDA | 9.04 |
PEG | 1.39 |
Shares Outstanding M | 211.60 |
Net Margin (%) | 8.00 |
Operating Margin % | 17.93 |
Pre-tax Margin (%) | 9.88 |
Quick Ratio | 0.57 |
Current Ratio | 1.10 |
ROA % (ttm) | 3.62 |
ROE % (ttm) | 7.86 |
ROIC % (ttm) | 6.86 |
Dividend Yield % | 3.85 |
Altman Z-Score | 1.56 |
DHA:ACMELAB Number of Guru Trades
DHA:ACMELAB Volume of Guru Trades
Gurus Latest Trades with DHA:ACMELAB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
DHA:ACMELAB is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data